These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8959489)

  • 1. Liver accumulation of TNP-modified streptavidin and avidin: potential use for targeted radio- and chemotherapy.
    Schechter B; Arnon R; Freedman YE; Chen L; Wilchek M
    J Drug Target; 1996; 4(3):171-9. PubMed ID: 8959489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody fragments in tumor pretargeting. Evaluation of biotinylated Fab' colocalization with recombinant streptavidin and avidin.
    Wilbur DS; Hamlin DK; Vessella RL; Stray JE; Buhler KR; Stayton PS; Klumb LA; Pathare PM; Weerawarna SA
    Bioconjug Chem; 1996; 7(6):689-702. PubMed ID: 8950488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organ selective delivery using a tissue-directed streptavidin--biotin system: targeting 5-fluorouridine via TNP-streptavidin.
    Schechter B; Chen L; Arnon R; Wilchek M
    J Drug Target; 1999; 6(5):337-48. PubMed ID: 10342382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization.
    Casalini P; Luison E; Ménard S; Colnaghi MI; Paganelli G; Canevari S
    J Nucl Med; 1997 Sep; 38(9):1378-81. PubMed ID: 9293791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug targeting to the brain using avidin-biotin technology in the mouse; (blood-brain barrier, monoclonal antibody, transferrin receptor, Alzheimer's disease).
    Jeong Lee H; Pardridge WM
    J Drug Target; 2000; 8(6):413-24. PubMed ID: 11328667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.
    Tseng CL; Su WY; Yen KC; Yang KC; Lin FH
    Biomaterials; 2009 Jul; 30(20):3476-85. PubMed ID: 19345990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity of streptavidin-blocked biotinyl-ricin is retrieved by in vitro immunotargeting via biotinyl monoclonal antibody.
    Schechter B; Arnon R; Wilchek M
    Cancer Res; 1992 Aug; 52(16):4448-52. PubMed ID: 1643636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the complement-mediated elimination of red blood cells modified with biotin and streptavidin.
    Muzykantov VR; Murciano JC; Taylor RP; Atochina EN; Herraez A
    Anal Biochem; 1996 Oct; 241(1):109-19. PubMed ID: 8921172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical modification of streptavidin and avidin: in vitro and in vivo analysis.
    Rosebrough SF; Hartley DF
    J Nucl Med; 1996 Aug; 37(8):1380-4. PubMed ID: 8708779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of [3H]biotin bound to different avidin analogues.
    Kang YS; Saito Y; Pardridge WM
    J Drug Target; 1995; 3(2):159-65. PubMed ID: 7496729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immobilized nitro-avidin and nitro-streptavidin as reusable affinity matrices for application in avidin-biotin technology.
    Morag E; Bayer EA; Wilchek M
    Anal Biochem; 1996 Dec; 243(2):257-63. PubMed ID: 8954558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue distribution of avidin and streptavidin injected to mice. Effect of avidin carbohydrate, streptavidin truncation and exogenous biotin.
    Schechter B; Silberman R; Arnon R; Wilchek M
    Eur J Biochem; 1990 Apr; 189(2):327-31. PubMed ID: 2186907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and biodistribution of radiolabeled avidin, streptavidin and biotin.
    Rosebrough SF
    Nucl Med Biol; 1993 Jul; 20(5):663-8. PubMed ID: 8358353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotin delivery to brain with a covalent conjugate of avidin and a monoclonal antibody to the transferrin receptor.
    Yoshikawa T; Pardridge WM
    J Pharmacol Exp Ther; 1992 Nov; 263(2):897-903. PubMed ID: 1432704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further studies on targeted DNA transfer to cells using a highly efficient delivery system of biotinylated transferrin and biotinylated polylysine complexed to streptavidin.
    Schoeman R; Joubert D; Ariatti M; Hawtrey AO
    J Drug Target; 1995; 2(6):509-16. PubMed ID: 7773613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of protein-coated liposomes in an extravascular site: influence of increasing carrier circulation lifetimes.
    Longman SA; Tardi PG; Parr MJ; Choi L; Cullis PR; Bally MB
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1177-84. PubMed ID: 8531079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice.
    Sato N; Kobayashi H; Saga T; Nakamoto Y; Ishimori T; Togashi K; Fujibayashi Y; Konishi J; Brechbiel MW
    Clin Cancer Res; 2001 Nov; 7(11):3606-12. PubMed ID: 11705883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system.
    Goodwin DA; Meares CF; Osen M
    J Nucl Med; 1998 Oct; 39(10):1813-8. PubMed ID: 9776294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous avidin chase improved localization of radiolabeled streptavidin in intraperitoneal xenograft pretargeted with biotinylated antibody.
    Zhang M; Sakahara H; Yao Z; Saga T; Nakamoto Y; Sato N; Nakada H; Yamashina I; Konishi J
    Nucl Med Biol; 1997 Jan; 24(1):61-4. PubMed ID: 9080476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal accumulation of streptavidin: potential use for targeted therapy to the kidney.
    Schechter B; Arnon R; Colas C; Burakova T; Wilchek M
    Kidney Int; 1995 May; 47(5):1327-35. PubMed ID: 7637262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.